RGLS
Regulus Therapeutics Inc.
10% owner David M Mott bought $1.2M of Regulus Therapeutics Inc.
Bought$1,227,640
$1.08Price
1,136,704Shares
+124%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
David M Mott's record
9 other buys with 3 months of prices since 2016: on average +19.6% against the S&P 500, and 7 of 9 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 7. Filed Thu, May 9, 2:06 PM ET, during the session. Not investment advice.